DIGITAL HEALTH NEWS

Welcome to #1 Digital Health News Portal.

Not a subscriber yet?
Get breaking DIGITAL HEALTH NEWS straight to your inbox. Subscribe now, it's free!

ICT & Ageing - European Study on Users, Markets and Technologies

ICT & Ageing - European Study on Users, Markets and TechnologiesThis document presents preliminary outcomes of an ongoing study entitled "ICT & Ageing - Users, Markets and Technologies". This two year research endeavour was launched in the beginning of 2008 by the European Commission, DG Information Society and Media. The general background to this study derives from the trend towards accelerating population ageing as it has been observed across Europe and beyond for some time already.

In Europe, average life expectancy has increased from 55 years in 1920 to over 80 years today. With the retiring baby boom generation the number of people aged between 65 and 80 years is expected to rise by nearly 40% between 2010 and 2030.2 For Europe and many other countries around the world, the ongoing demographic development has significant socio-economic implications: in the future, there will be more older people in absolute as well as relative terms, there will be considerably more old people particularly in the upper age range, there will be fewer family carers providing informal support to these, and there will be a smaller productive workforce to contribute to the creation of economic wealth in general and to the financing of health and social services in particular.

Download ICT & Ageing - European Study on Users, Markets and Technologies Preliminary Findings (.pdf, 694 KB).

Download from the eHealthNews.EU Portal's mirror: ICT & Ageing - European Study on Users, Markets and Technologies Preliminary Findings (.pdf, 694 KB).

For further information, please visit:
http://www.ict-ageing.eu

Related news articles:

About empirica
empirica Gesellschaft für Kommunikations- und Technologieforschung mbH (empirica) has many years of experience in quantitative and qualitative research methods. Its clients are private companies and public bodies: large and medium-sized companies in the insurance, pharmaceutical and automobile industries as well as software developers and hardware manufacturers. There are also telecommunications service companies and network providers, social services firms, medical facilities, Federal and State Government ministries in Germany and the European Commission as well as the European statistical office (Eurostat). For further information, please visit www.empirica.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...